1-(1-(4-methylbenzyl)indolin-5-yl)-3-(pyridin-4-ylmethyl)urea

ID: ALA4878914

PubChem CID: 164627527

Max Phase: Preclinical

Molecular Formula: C23H24N4O

Molecular Weight: 372.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(CN2CCc3cc(NC(=O)NCc4ccncc4)ccc32)cc1

Standard InChI:  InChI=1S/C23H24N4O/c1-17-2-4-19(5-3-17)16-27-13-10-20-14-21(6-7-22(20)27)26-23(28)25-15-18-8-11-24-12-9-18/h2-9,11-12,14H,10,13,15-16H2,1H3,(H2,25,26,28)

Standard InChI Key:  KXOLQGUPBUNOAD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    7.0275  -10.2747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0264  -11.1020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7412  -11.5149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4576  -11.1016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4547  -10.2710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7393   -9.8619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1676   -9.8558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8837  -10.2657    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5965   -9.8505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3126  -10.2602    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5934   -9.0255    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0254   -9.8451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7374  -10.2567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7261   -8.6067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0166   -9.0236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4471   -9.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4506   -9.8420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2369  -10.0938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7194   -9.4237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2313   -8.7580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4829   -7.9722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2891   -7.7973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8397   -8.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6453   -8.2364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8976   -7.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3381   -6.8379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5347   -7.0155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7036   -7.2741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 12 13  2  0
 13 17  1  0
 16 14  1  0
 14 15  2  0
 15 12  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 25 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4878914

    ---

Associated Targets(Human)

NAMPT Tchem Nicotinamide phosphoribosyltransferase (3221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.1950AlogP: 4.27#Rotatable Bonds: 5
Polar Surface Area: 57.26Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.02CX LogP: 3.99CX LogD: 3.99
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.70Np Likeness Score: -1.90

References

1. Akiu M, Tsuji T, Sogawa Y, Terayama K, Yokoyama M, Tanaka J, Asano D, Sakurai K, Sergienko E, Sessions EH, Gardell SJ, Pinkerton AB, Nakamura T..  (2021)  Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition.,  43  [PMID:33887438] [10.1016/j.bmcl.2021.128048]

Source